The normal neuroendocrine cells of the upper gastrointestinal tract lack E-cadherin

References

• Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009;457:608–11.
   PubMed Web of Science ®Google Scholar
• Trivedi N, Hollister-Lock J, Lopez-Avalos MD, O’Neil JJ, Keegan M, Bonner-Weir S, et al. Increase in beta-cell mass in transplanted porcine neonatal pancreatic cell clusters is due to proliferation of beta-cells and differentiation of duct cells. Endocrinology 2001;142:2115–22.
   PubMed Web of Science ®Google Scholar
• Georgia S, Bhushan A. Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J Clin Invest 2004;114:963–8.
   PubMed Web of Science ®Google Scholar
• Eusebi V, Damiani S, Pasquinelli G, Lorenzini P, Reuter VE, Rosai J. Small cell neuroendocrine carcinoma with skeletal muscle differentiation: report of three cases. Am J Surg Pathol 2000;24:223–30.
   PubMed Web of Science ®Google Scholar
• Creutzfeldt W. The achlorhydria-carcinoid sequence: role of gastrin. Digestion 1988;39:61–79.
   PubMed Web of Science ®Google Scholar
• Havu N. Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 1986;35:42–55.
   PubMed Web of Science ®Google Scholar
• Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE. Increased cell division as a cause of human cancer. Cancer Res 1990;50:7415–21.
   PubMed Web of Science ®Google Scholar
• Macdonald RA. A study of 356 carcinoids of the gastrointestinal tract; report of four new cases of the carcinoid syndrome. Am J Med 1956;21:867–78.
   PubMed Web of Science ®Google Scholar
• Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998;392:402–5.
   PubMed Web of Science ®Google Scholar
• Oliveira C, Senz J, Kaurah P, Pinheiro H, Sanges R, Haegert A, et al. Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum Mol Genet 2009;18:1545–55.
   PubMed Web of Science ®Google Scholar
• Ascano JJ, Frierson H Jr, Moskaluk CA, Harper JC, Roviello F, Jackson CE, et al. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer. Mod Pathol 2001;14:942–9.
   PubMed Web of Science ®Google Scholar
• Blok P, Craanen ME, Dekker W, Tytgat GN. Loss of E-cadherin expression in early gastric cancer. Histopathology 1999;34:410–15.
   PubMed Web of Science ®Google Scholar
• Waldum HL, Haugen OA, Isaksen C, Mecsei R, Sandvik AK. Are diffuse gastric carcinomas neuroendocrine tumours? (ECL-omas). Eur J Gastroenterol Hepatol 1991;3:245–9.
   Web of Science ®Google Scholar
• Waldum HL, Aase S, Kvetnoi I, Brenna E, Sandvik AK, Syversen U, et al. Neuroendocrine differentiation in human gastric carcinoma. Cancer 1998;83:435–44.
   PubMed Web of Science ®Google Scholar
• Qvigstad G, Sandvik AK, Brenna E, Aase S, Waldum HL. Detection of chromogranin A in human gastric adenocarcinomas using a sensitive immunohistochemical technique. Histochem J 2000;32:551–6.
   PubMedGoogle Scholar
• Qvigstad G, Qvigstad T, Westre B, Sandvik AK, Brenna E, Waldum HL. Neuroendocrine differentiation in gastric adenocarcinomas associated with severe hypergastrinemia and/or pernicious anemia. APMIS 2002;110:132–9.
   PubMed Web of Science ®Google Scholar
• Bakkelund K, Fossmark R, Nordrum I, Waldum H. Signet ring cells in gastric carcinomas are derived from neuroendocrine cells. J Histochem Cytochem 2006;54:615–21.
   PubMed Web of Science ®Google Scholar
• Sordal O, Qvigstad G, Nordrum IS, Waldum HL. Evaluation of mucin and neuroendocrine expression in dffuse gastric cancer with signet ring cell morphology. DDW abstract 2013. A–1346.
   Google Scholar
• Barrett P, Hobbs RC, Coates PJ, Risdon RA, Wright NA, Hall PA. Endocrine cells of the human gastrointestinal tract have no proliferative capacity. Histochem J 1995;27:482–6.
   PubMedGoogle Scholar
• Waldum HL, Brenna E. Non-proliferative capacity of endocrine cells of the human gastro-intestinal tract. Histochem J 1996;28:397–8.
   PubMedGoogle Scholar
• Qvigstad G, Falkmer S, Westre B, Waldum HL. Clinical and histopathological tumour progression in ECL cell carcinoids ("ECLomas"). APMIS 1999;107:1085–92.
   PubMed Web of Science ®Google Scholar
• Galvan JA, Astudillo A, Vallina A, Fonseca PJ, Gomez-Izquierdo L, Garcia-Carbonero R, et al. Epithelial-mesenchymal transition markers in the differential diagnosis of gastroenteropancreatic neuroendocrine tumors. Am J Clin Pathol 2013;140:61–72.
   PubMed Web of Science ®Google Scholar
• Sun X, Gong Y, Talamonti MS, Rao MS. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in carcinoid tumors. Mod Pathol 2002;15:1333–8.
   PubMed Web of Science ®Google Scholar
• Boo YJ, Park SS, Kim JH, Mok YJ, Kim SJ, Kim CS. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers. J Surg Oncol 2007;95:110–17.
   PubMed Web of Science ®Google Scholar
• Kidd M, Modlin IM, Pfragner R, Eick GN, Champaneria MC, Chan AK, et al. Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-beta1-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1. Cancer 2007;109:2420–31.
   PubMed Web of Science ®Google Scholar
• Simonsson M, Eriksson S, Hakanson R, Lind T, Lonroth H, Lundell L, et al. Endocrine cells in the human oxyntic mucosa. A histochemical study. Scand J Gastroenterol 1988;23:1089–99.
   PubMed Web of Science ®Google Scholar